Categories
Uncategorized

May is Skin Cancer Awareness Month

img_5791.jpg

It’s time to Slip, Slop, Slap, Seek and Slide (https://www.youtube.com/watch?v=FzA47J7QsVk) and so therefore it must be skin cancer awareness month. Chris T Bear has already done the appropriate thing and slid on his sunglasses, and here is some information including up to date evidence and guidance when it comes to skin cancer.

skin cancerInfographic via Cancer Research UK accessed 26/05/17

“Excluding non-melanoma, melanoma is the fifth most common cancer in the UK. Around 13,500 new cases of melanoma are diagnosed each year.

More than a quarter of skin cancer cases are diagnosed in people under 50, which is unusually early compared to most other types of cancer.

Over recent years, skin cancer has become much more common in the UK. This is thought to be the result of increased exposure to intense sunlight while on holiday abroad.”

Information on Melanoma aimed at patients available from www.nhs.uk – accessed 26/05/17

Find the Pathway

Skin cancer – everything NICE says in an interactive flowchart https://pathways.nice.org.uk/pathways/skin-cancer

Melanoma https://pathways.nice.org.uk/pathways/melanoma

Get the NICE Guidance

Christie Research

Skin microtopography as a measure of photoaging and risk of squamous cell carcinoma of the skin in a US population.

Prevalence of skin cancer and related skin tumors in high-risk kidney and liver transplant recipients in Queensland, Australia.

Black tea consumption and risk of skin cancer: an 11-year prospective study.

Radiotherapy treatment of non-melanoma skin cancer: a survey of current UK practice and commentary.

skin-cancer.jpg

Image via www.nhs.uk

Behind the Headlines

“Expanding waistline linked to an increased risk of cancer”

‘Secret ginger gene’ may increase skin cancer risk for millions”

Treatment ‘breakthrough’ in man with advanced skin cancer

Cochrane Clinical Answers:

How do psychosocial interventions affect quality of life and emotional wellbeing in people with recently diagnosed cancer?

In people with primary cutaneous melanoma, how do surgical excision margins affect outcomes?

What are the benefits and harms of the adjuvant treatment interferon alpha in people with stage II or III cutaneous melanoma?